Recent Publications from the Lindner Lab

Research Publications Cell Biology

 

Duarte CW, Stohn JP, Wang Q, Emery IF, Prueser A, Lindner V. 2014. Elevated plasma levels of the pituitary hormone cthrc1 in individuals with red hair but not in patients with solid tumors. PLoS One 9: e100449.  books

Marks PC, Preda M, Henderson T, Liaw L, Lindner V, Friesel RE, Pinz IM. 2013. Interactive 3D analysis of blood vessel trees and collateral vessel volumes in magnetic resonance angiograms in the mouse ischemic hindlimb model. Open Med Imaging 7: 19-27.  books

Boucher JM, Harrington A, Rostama B, Lindner V, Liaw L. 2013. A receptor-specific function for Notch2 in mediating vascular smooth muscle cell growth arrest through p27kip1. Circ Res. 113: 975-985. books

Liu G, Sengupta PK, Jamal B, Yang HY, Bouchie MP, Lindner V, Varelas X, Kukuruzinska MA. 2013. N-glycosylation induces the CTHRC1 protein and drives oral cancer cell migration. J Biol Chem. 288: 20217-20227. books

Young K, Conley B, Romero D, Tweedie E, O'Neill C, Pinz I, Brogan L, Lindner V, Liaw L, Vary CP. 2012. BMP9 regulates endoglin-dependent chemokine responses in endothelial cells. Blood 120: 4263-4273. books

Stohn JP, Perreault NG, Wang Q, Liaw L, Lindner V. 2012. Cthrc1, a novel circulating hormone regulating metabolism. PLoS One 7: e47142. books

Apra C, Richard L, Coulpier F, Blugeon C, Gilardi-Hebenstreit P, Vallat JM, Lindner V, Charnay P, Decker L. 2012. Cthrc1 is a negative regulator of myelination in Schwann cells. Glia 60: 393-403. books

Larman BW, Karolak MJ, Lindner V, Oxburgh L. 2012. Distinct bone morphogenetic proteins activate indistinguishable transcriptional responses in nephron epithelia including Notch target genes. Cell Signal 24: 257-264. books

Cuttler AS, LeClair RJ, Stohn JP, Wang Q, Sorenson CM, Liaw L, Lindner V. 2011. Characterization of Pdgfrb-Cre transgenic mice reveals reduction of ROSA26 reporter activity in remodeling arteries. Genesis 49: 673-680. books

McCulloch DR, Nelson CM, Dixon LJ, Silver DL, Wylie JD, Lindner V, Sasaki T, Cooley MA, Argraves WS, Apte SS. 2009. ADAMTS metalloproteases generate active versican fragments that regulate interdigital web regression. Dev Cell 17: 687-698. books

Marzoll A, Nagy N, Wördehoff L, Dai G, Fries S, Lindner V, Grosser T, Fischer JW. 2009. Cyclooxygenase inhibitors repress vascular hyaluronan-synthesis in murine atherosclerosis and neointimal thickening. J Cell Mol Med. 13: 3713-3719. books

Yang X, Harkins LK, Zubanova O, Harrington A, Kovalenko D, Nadeau RJ, Chen PY, Toher JL, Lindner V, Liaw L, Friesel R. 2008. Overexpression of Spry1 in chondrocytes causes attenuated FGFR ubiquitination and sustained ERK activation resulting in chondrodysplasia. Dev Biol. 321: 64-76. books

Connerney J, Andreeva V, Leshem Y, Mercado MA, Dowell K, Yang X, Lindner V, Friesel RE, Spicer DB. 2008. Twist1 homodimers enhance FGF responsiveness of the cranial sutures and promote suture closure. Dev Biol. 318: 323-334. books

Leclair RJ, Wang Q, Benson MA, Prudovsky I, Lindner V. 2008. Intracellular localization of Cthrc1 characterizes differentiated smooth muscle. Arterioscler Thromb Vasc Biol. 28: 1332-1338. books

LeClair R, Lindner V. 2007. The role of collagen triple helix repeat containing 1 in injured arteries, collagen expression, and transforming growth factor beta signaling. Trends Cardiovasc Med. 17: 202-205. books

LeClair RJ, Durmus T, Wang Q, Pyagay P, Terzic A, Lindner V. 2007. Cthrc1 is a novel inhibitor of transforming growth factor-beta signaling and neointimal lesion formation. Circ Res. 100: 826-833. books

Durmus T, LeClair RJ, Park KS, Terzic A, Yoon JK, Lindner V. 2006. Expression analysis of the novel gene collagen triple helix repeat containing-1 (Cthrc1). Gene Expr Patterns 6: 935-940. books

Pyagay P, Heroult M, Wang Q, Lehnert W, Belden J, Liaw L, Friesel RE, Lindner V. 2005. Collagen triple helix repeat containing 1, a novel secreted protein in injured and diseased arteries, inhibits collagen expression and promotes cell migration. Circ Res. 96: 261-268. books

Lindner V, Wang Q, Conley BA, Friesel RE, Vary CP. 2005. Vascular injury induces expression of periostin: implications for vascular cell differentiation and migration. Arterioscler Thromb Vasc Biol. 25: 77-83. books

Mandinov L, Mandinova A, Kyurkchiev S, Kyurkchiev D, Kehayov I, Kolev V, Soldi R, Bagala C, de Muinck ED, Lindner V, Post MJ, Simons M, Bellum S, Prudovsky I, Maciag T. 2003. Copper chelation represses the vascular response to injury. Proc Natl Acad Sci U S A. 100: 6700-5. books

Myers DL, Harmon KJ, Lindner V, Liaw L. 2003. Alterations of arterial physiology in osteopontin-null mice. Arterioscler Thromb Vasc Biol. 23: 1021-1028. books

Ryan ST, Koteliansky VE, Gotwals PJ, Lindner V. 2003. Transforming growth factor-beta-dependent events in vascular remodeling following arterial injury. J Vasc Res. 40: 37-46. books

de Waard V, Arkenbout EK, Carmeliet P, Lindner V, Pannekoek H. 2002. Plasminogen activator inhibitor 1 and vitronectin protect against stenosis in a murine carotid artery ligation model. Arterioscler Thromb Vasc Biol. 22: 1978-1983. books

Grzeszkiewicz TM, Lindner V, Chen N, Lam SC, Lau LF. 2002. The angiogenic factor cysteine-rich 61 (CYR61, CCN1) supports vascular smooth muscle cell adhesion and stimulates chemotaxis through integrin alpha(6)beta(1) and cell surface heparan sulfate proteoglycans. Endocrinology 143: 1441-1450. books

Apply to the Sackler School

apply

The priority application deadlines are as follows:

December 1: Basic Science Division PhD Programs

February 15: Building Diversity in Biomedical Sciences

March 31: Post-Baccalaureate Research Program

May 1: Clinical & Translational Science, MS in Pharmacology & Drug Development

June 15: Online Certificate in Fundamentals of Clinical Care Research